Systolic hypertension in older persons - Controversies and indications for treatment;Skurczowe nadciśnienie tetnicze u osób w wieku podeszłym - Kontrowersje i wskazania do leczenia

Advances in Clinical and Experimental Medicine

Volumn 15, Issue 3, 2006, Pages 521-526

  Juszczyk, Zdzisław ^a,b  

^a Szpital w Bia ej Prudnickiej   (Poland)

^b NONE   (Poland)

Author keywords

Elderly; Systolic hypertension; Treatment

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CARVEDILOL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; LACIDIPINE; LOSARTAN; METOPROLOL; NITRENDIPINE; PERINDOPRIL; PINDOLOL; THIAZIDE DIURETIC AGENT;

AGED; AGING; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; PUBLIC HEALTH; PULSE PRESSURE; STROKE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TREATMENT INDICATION; WESTERN HEMISPHERE; WHITE COAT HYPERTENSION;

EID: 33746136949     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Primatesta P, Poulter N: Hypertension in the elderly in England. J Hypertens 2004, 22, 1093-1098.
2. Sagin A, Larson M, Levy D: The natural history of borderline isolated systolic hypertension. N Engl J Med 1993, 329, 1912-1917.
3. Psaty B, Furberg C, Kuller L: Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med 1999, 159, 1339-1347.
4. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in Elderly Program (SHEP) JAMA 1991, 265, 3255-3264.
5. Liu L, Wang J, Gong L, Liu G, Staessen J: Comparison of active treatment and placebo in older Chinese patients with systolic hypertension. J Hum Hypertens 1998, 16, 1823-1829.
6. Staessen J, Fagard R, Thijs L, Cellis H, Arabidze G, Birgenhager W, Bulpitt C, De Leeuw P, Dollery C, Flether A, Forette L, Leonetti G, Nachev C, O'Brien E, Rosenfeld J, Rodicio J, Tuomilehto J, Zanchetti A: Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997, 350, 757-764.
7. Malacco E, Mancia G, Rappelli A, Menotti A, Zuccaro M, Coppini A: Treatment of isolated hypertension: the SHELL study results. Blood Press 2003, 12, 160-167.
8. Lever A, Brennan P: MRC trial of treatment in elderly hypertensives. Clin Exp Hypertens 1993, 15, 941-942.
9. Lithell H, Hansson L, Swoog I, Eimfeldt G, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A: The Study on Cognition and Prognosis in Elderly (SCOPE) principal results of the randomized double-blind interventional study. J Hypertens 2003, 21, 875-886.
10. Moser M: White coat hypertension to treat or not to treat: a clinical dilemma. Arch Intern Med 2001, 161, 2655-2656.
11. O'Brien E, Asmar R, Beilin L, Imai Y, Mallon M, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou J, Verdecchia P: On behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. J Hypertens 2003, 21, 821-848.
12. Kario K: Blood pressure variability in hypertension. A possible cardiovascular risk factor. Am J Hypertens 2004, 17, 1075-1076.
13. Kario K, Pickering T, Umeda Y: Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003, 107, 1401-1406.
14. Halawa B, Kalicińska E: Poranny wzrost ciśnienia tetniczego a zagrożenie schorzeniami sercowo-naczyniowymi. Adv Clin Exp Med 2005, 14, 195-197.
15. Hermida R, Ayala D, Calvo C: Administration-time-dependent effects of antihypertensive treatment on the cicardian pattern of blood pressure. Curr Opin Nephrol Hypertens 2005, 14, 453-459.
16. Barriuoso R, Benegas J, Damian J, Appel L, Guallar E: Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med 2003, 139, 731-739.
17. Cushman W, Materson B, Williams D, Reda D: Pulse pressure changes with sex classes of antihypertensive agends in a randomized, controlled trial. Hypertension 2001, 38, 953, 957.
18. Safer M, Vaisse B, Blacher J, Rudnichi A, Mourad J: Pulse pressure monitoring of open antihypertensive therapy. Am J Hypertens 2004, 17, 1088-1094.
19. Chang J, Luchsinger J, Shea S: Antihypertensive medication class and pulse pressure in elderly: analysis based on the Third National Health and Nutrition Examination Survey. Am J Med 2003, 115, 536-542.
20. Miguel A, Jimenez-Garcia R, San Martin M, Gonzalez I, Vegacampo A, Martinez-Gonzalez J, Herrero G: Drug surveillance study of amlodipine in patients with hypertension not controlled with drug therapy NORCON study. Curr Ther Res 2000, 61, 863-870.
21. Forette F, Seux M, Staessen J: Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352, 1347-1351.
22. Dahlof B, Lindholm L, Hansson L, Schersten B, Ekbom T, Wester P: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991, 338, 1281-1285.
23. Collaborative Group Randomized trial of the perindopril-based blood-pressure-lowering regiment among 6105 individuals with previous stroke or transit ischaemic attack. Lancet 2001, 358, 1033-1041.
24. The PROGRESS Collaborative Group. Effect of blood pressure lowering with perindopril and indapamine therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Inter Med 2003, 163, 1069-1075.
25. Dahlof B, Devereux R, Kjedsen S, Julius S, Beevers G, de Faoire U, Fuhrquist F, Ibsen H, Nieminen M, Omvuk P, Oparil S, Wedel H: Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002, 359, 995-1003.
26. Whelton P, Appel L, Espeland L: Sodium reduction, and weight loss in the treatment in hypertension in older persons: a randomized controlled trial of non-pharmacologic intervention in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998, 279, 839-846.
27. Chaudhey I, Krumholtz M, Foody J: Systolic hypertension in older persons. JAMA 2004, 292, 1074-1080.
28. The Seventh Report of Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC Report. JAMA, 2003, 289, 2534-2573.
29. European Society of Hypertension-European Society of Cardiology guidelines for management of arterial hypertension.. Guidelines Committee 2003. J Hypertens 2003, 21, 1011-1073.